Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct 13;60(4):2103181.
doi: 10.1183/13993003.03181-2021. Print 2022 Oct.

Diagnostic, prognostic and differential-diagnostic relevance of pulmonary haemodynamic parameters during exercise: a systematic review

Affiliations

Diagnostic, prognostic and differential-diagnostic relevance of pulmonary haemodynamic parameters during exercise: a systematic review

Katarina Zeder et al. Eur Respir J. .

Abstract

Background: The cardiopulmonary haemodynamic profile observed during exercise may identify patients with early-stage pulmonary vascular and primary cardiac diseases, and is used clinically to inform prognosis. However, a standardised approach to interpreting haemodynamic parameters is lacking.

Methods: We performed a systematic literature search according to PRISMA guidelines to identify parameters that may be diagnostic for an abnormal haemodynamic response to exercise and offer optimal prognostic and differential-diagnostic value. We performed random-effects meta-analyses of the normal values and report effect sizes as weighted mean±sd. Results of diagnostic and prognostic studies are reported descriptively.

Results: We identified 45 eligible studies with a total of 5598 subjects. The mean pulmonary arterial pressure (mPAP)/cardiac output (CO) slope, pulmonary arterial wedge pressure (PAWP)/CO slope and peak cardiac index (or CO) provided the most consistent prognostic haemodynamic parameters during exercise. The best cut-offs for survival and cardiovascular events were a mPAP/CO slope >3 Wood units (WU) and PAWP/CO slope >2 WU. A PAWP/CO slope cut-off >2 WU best differentiated pre- from post-capillary causes of PAP elevation during exercise. Upper limits of normal (defined as mean+2sd) for the mPAP/CO and PAWP/CO slopes were strongly age-dependent and ranged in 30-70-year-old healthy subjects from 1.6 to 3.3 WU and 0.6 to 1.8 WU, respectively.

Conclusion: An increased mPAP/CO slope during exercise is associated with impaired survival and an independent, prognostically relevant cut-off >3 WU has been validated. A PAWP/CO slope >2 WU may be suitable for the differentiation between pre- and post-capillary causes of PAP increase during exercise.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: K. Zeder reports payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from Janssen, and support for attending meetings and/or travel from MSD and Ferrer. B.A. Maron reports grants from Actelion Pharmaceuticals, Tenax Therapeutics, Regeneron Pharmaceuticals, Deerfield Corporation and NIH Research, and discloses the following patents: U.S. Patent #9,605,047, PCT/US2020/066886, PCT/US2019/059890 and PCT/US2015/029672. A. Berghold reports participation on a data safety monitoring board or advisory board for Roche. H. Olschewski reports consulting fees from Actelion, Chiesi, AstraZeneca, GSK, Bayer, Inventiva, Boehringer, Ferrer, Janssen, Menarini, MSD and Novartis, payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from Springer and Medupdate, support for attending meetings and/or travel from Boehringer and Menarini, participation on a data safety monitoring board or advisory board for Aerovate, Bayer and Pfizer, receipt of equipment, materials, drugs, medical writing, gifts or other services from Algorithm Sciences, Boehringer and Inventiva, and is Deputy Director of the Ludwig Boltzmann Institute for Lung Vascular Research, Graz. The remaining authors disclose no potential conflicts of interest.

Figures

FIGURE 1
FIGURE 1
a) Mean pulmonary arterial pressure (mPAP)/cardiac output (CO) slope (Wood units (WU) and b) pulmonary arterial wedge pressure (PAWP)/CO slope (WU) by age group in the supine position. Each line represents an individual study group or a subgroup according to stratification to age in one study (see figure 2 for details). Older subjects (blue line) had a steeper mPAP/CO and PAWP/CO slope and tended to have higher mPAP at rest. During exercise, older subjects reach higher mPAP and PAWP at lower CO values as than younger individuals. The solid black lines show the age-adjusted mean slopes (estimated by mean age across the included studies). Exercise values in healthy subjects did not exceed mPAP >30 mmHg in combination with exercise total pulmonary resistance >3 WU (dashed line in figure 1a).
FIGURE 2
FIGURE 2
Forrest plots of the identified studies in healthy subjects in the supine position for a) mean age (years), b) mean pulmonary arterial pressure (mPAP)/cardiac output (CO) slope (Wood units (WU)) and c) pulmonary arterial wedge pressure (PAWP)/CO slope (WU). Estimates were computed using the Knapp–Hartung correction due to the low number of available studies. The study of Wolsk et al. [65] assessed different age groups that are separately displayed in the Forrest plot, showing the influence of age on cardiopulmonary haemodynamic parameters during exercise. Wolsk et al. 2017­_1 provided the youngest age group (<40 years) and Wolsk et al. 2017­_3 the oldest ( >60 years) [65].
FIGURE 3
FIGURE 3
Mean pulmonary arterial pressure (mPAP)/cardiac output (CO), pulmonary arterial wedge pressure (PAWP)/CO and trans-pulmonary gradient (TPG)/CO slopes for the characterisation of pulmonary haemodynamic parameters during exercise. Abnormal pulmonary haemodynamic parameters during exercise may be defined by an increased mPAP/CO slope. This slope is strongly age-dependent and its upper limit of normal (ULN) (mean+2sd) ranges from 1.6 Wood units (WU) (in ∼30-year-old healthy subjects) to 3.3 WU (in ∼70-year-old healthy subjects) in the supine position (table 2). The ULN based on the weighted mean and sd of all healthy subjects included in this analysis was 2.7 WU in the supine position. An increased mPAP/CO slope with a cut-off above >3 WU is independently associated with poor survival and heart failure-related hospitalisations. The mPAP/CO slope corresponds to the sum of the TPG/CO slope and the PAWP/CO slope. Like the mPAP/CO slope, the PAWP/CO slope is also strongly age-dependent and its ULN ranges from 0.6 to 1.8 WU. An increased PAWP/CO slope with a cut-off >2 WU is associated with impaired survival and increased cardiovascular (CV) events and may be diagnostic for a post-capillary cause of PAP elevation during exercise. The ULN for the TPG/CO slope is 1.2 WU and age-independent. An increased TPG/CO slope is also associated with impaired survival and may be suggestive of pulmonary vascular disease (PVD). Studies reporting on the prognostic relevance of the mPAP/CO, TPG/CO and PAWP/CO slopes are indicated in the footnotes. LHD: left heart disease. #: for validating mPAP/CO >3 WU cut-off [31], and [12, 42, 44, 45, 48]; : for validating mPAP/CO >3 WU cut-off [31]; +: [31, 48]; §: [31]; ƒ: [, , –63]; ##: for validating PAWP/CO >2 WU cut-off [32], and [31, 33]; ¶¶: for validating PAWP/CO >2 WU cut-off [32], and [31]; ++: for validating PAWP/CO >2 WU cut-off [32], and [54].

References

    1. Kovacs G, Berghold A, Scheidl S, et al. . Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review. Eur Respir J 2009; 34: 888–894. doi:10.1183/09031936.00145608 - DOI - PubMed
    1. World Health Organization Expert Committee on Chronic Cor Pulmonale . Chronic Cor Pulmonale: Report of an Expert Committee [meeting held in Geneva from 10 to 15 October 1960]. 1961. Available from: https://apps.who.int/iris/handle/10665/40483
    1. Hatano S, Strasser T, World Health Organization . Primary Pulmonary Hypertension: Report on a WHO Meeting, Geneva, 15–17 October 1973. 1975. Available from: https://apps.who.int/iris/handle/10665/39094
    1. Galiè N, Torbicki A, Barst R, et al. . Guidelines on diagnosis and treatment of pulmonary arterial hypertension: The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Eur Heart J 2004; 25: 2243–2278. doi:10.1016/j.ehj.2004.09.014 - DOI - PubMed
    1. Rich S, Dantzker DR, Ayres SM, et al. . Primary pulmonary hypertension. A national prospective study. Ann Intern Med 1987; 107: 216–223. doi:10.7326/0003-4819-107-2-216 - DOI - PubMed

Publication types